Cubist Pharmaceuticals
Cubist Pharmaceuticals is a biopharmaceutical company developing and commercializing pharmaceutical products founded in 1992.
All edits
CUBICIN®, (daptomycin for injection), its marketed product, has been used for treating more than an estimated 1.1 million patients with serious infections. CUBICIN has generated millions of dollars in annual sales that helped propel Cubist into one of the Commonwealth's best-performing firms as evidenced by recent recognition. Cubist Pharmaceuticals is a wholly owned subsidiary of Merck & CoMerck & Co.
Cubist Pharmaceuticals is a biopharmaceutical company that is developing and commercializing pharmaceutical products. Cubist focuses on research, commercialization and creation of pharmaceutical products that help to address unmet medical needs in the acute care environment.
CUBICIN®, (daptomycin for injection), its marketed product, has been used for treating more than an estimated 1.1 million patients with serious infections. CUBICIN has generated millions of dollars in annual sales that helped propel Cubist into one of the Commonwealth's best-performing firms as evidenced by recent recognition. Cubist Pharmaceuticals is a wholly owned subsidiary of Merck & Co.
Find more companies like Cubist Pharmaceuticals
